November 1, 2023 – Page 3

Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA® (vonoprazan) Tablets for the Treatment of Erosive GERD and Relief of Heartburn Associated with Erosive GERD in Adults

Written by Customer Service on November 1, 2023. Posted in Public Companies.

VOQUEZNA® (vonoprazan) product photos VOQUEZNA® (vonoprazan) 20 mg and 10 mg bottle VOQUEZNA® (vonoprazan) product photos VOQUEZNA® (vonoprazan) 10 mg and 20 mg tablet FDA approval marks the first major innovation to the U.S. Erosive GERD market in over 30 years VOQUEZNA® met the primary endpoints and key secondary superiority endpoints in the pivotal Phase 3 PHALCON-EE trial evaluating VOQUEZNA in comparison to a standard-of-care proton pump inhibitor (PPI)1 Commercial availability of VOQUEZNA expected December 2023 Erosive GERD approval provides Phathom $175 million under its revenue interest financing agreement Conference call and webcast scheduled for November 2, 2023, at 11:00 a.m. ET FLORHAM PARK, N.J., Nov. 01, 2023 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company...

NVIDIA Sets Conference Call for Third-Quarter Financial Results

Written by Customer Service on November 1, 2023. Posted in Public Companies.

CFO Commentary to Be Provided in Writing Ahead of Call SANTA CLARA, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) — NVIDIA will host a conference call on Tuesday, Nov. 21, at 2 p.m. PT (5 p.m. ET), to discuss its financial results for the third quarter of fiscal year 2024, which ended Oct. 29, 2023. The call will be webcast live (in listen-only mode) on investor.nvidia.com. The company’s prepared remarks will be followed by a question-and-answer session, which will be limited to questions from financial analysts and institutional investors. Ahead of the call, NVIDIA will provide written commentary on its third-quarter results from its CFO, Colette Kress. This material will be posted to investor.nvidia.com immediately after the company’s results are publicly announced at approximately 1:20 p.m. PT. The webcast will be recorded and available...

Ashland provides update on fiscal 2023 fourth-quarter and full-year earnings1 and announces upcoming portfolio-optimization actions; sets date for fiscal 2023 fourth-quarter earnings release

Written by Customer Service on November 1, 2023. Posted in Earnings Releases And Operating Results.

Results in the fourth quarter reflect a customer-demand environment that was generally consistent with expectations Fourth-quarter and full-year earnings are below expectations driven primarily by additional inventory-control actions Initiation of portfolio-optimization actions to further strengthen resilience and improve profitability. WILMINGTON, Del., Nov. 01, 2023 (GLOBE NEWSWIRE) — Ashland Inc. (NYSE: ASH) today provided an update for preliminary fiscal 2023 fourth-quarter results, full-year sales and Adjusted EBITDA.1 Ashland’s financial results during the quarter reflect market-demand dynamics and underlying business performance that were generally consistent with previously communicated expectations. Earnings for the quarter were most directly impacted by additional inventory-reduction actions taken to better position...

Viemed Healthcare Announces Record Third Quarter 2023 Financial Results

Written by Customer Service on November 1, 2023. Posted in Earnings Releases And Operating Results.

LAFAYETTE, La., Nov. 01, 2023 (GLOBE NEWSWIRE) — Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three and nine months ended September 30, 2023. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended September 30, 2023 reached a new Company record of $49.4 million, representing an increase of $13.6 million, or 38%, over net revenues reported for the comparable quarter ended September 30, 2022. This represents 14% sequential growth in revenue over the quarter ended June 30, 2023. Net income for the quarter ended September 30, 2023 totaled $2.9 million, representing an increase of $1.9 million, or 177%, over...

National Fuel Reports Fourth Quarter and Full Year Fiscal 2023 Earnings

Written by Customer Service on November 1, 2023. Posted in Earnings Releases And Operating Results.

WILLIAMSVILLE, N.Y., Nov. 01, 2023 (GLOBE NEWSWIRE) — National Fuel Gas Company (“National Fuel” or the “Company”) (NYSE:NFG) today announced consolidated results for the three months and fiscal year ended September 30, 2023. FISCAL 2023 FOURTH QUARTER SUMMARY GAAP net income of $73.7 million, or $0.80 per share, compared to GAAP net income of $158.1 million, or $1.71 per share, in the prior year. Adjusted operating results of $72.2 million, or $0.78 per share, compared to $109.3 million, or $1.19 per share, in the prior year (see non-GAAP reconciliation on page 2 for fourth quarter and fiscal 2023). Both E&P segment net production and Gathering segment revenue increased by 7% versus the prior year, driven by continued strong operational execution in Appalachia. Supply Corporation entered into a precedent agreement with Seneca...

Cellectis to Report Third Quarter 2023 Financial Results on November 6, 2023

Written by Customer Service on November 1, 2023. Posted in Public Companies.

NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that it will report financial results for the third quarter ended September 30, 2023 on Monday, November 6, 2023 after the close of the US market. The announcement will be followed by an investor conference call and webcast on Tuesday, November 7, 2023 at 8:00 AM ET / 2:00 PM CET. The call will include the Company’s third quarter results and an update on business activities. Details for the call are as follows: Dial in information: Domestic: 1-877-451-6152 International: 1-201-389-0879 Conference ID: 13741035 Webcast Link: https://viavid.webcasts.com/starthere.jsp?ei=1632799&tp_key=bff99741ab About...

Pennant Acquires Northern Texas and Southern Oklahoma Hospice Provider

Written by Customer Service on November 1, 2023. Posted in Mergers And Acquisitions.

EAGLE, Idaho, Nov. 01, 2023 (GLOBE NEWSWIRE) — The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, today announced that it has acquired Guardian Hospice and Guardian Hospice of Oklahoma (“Guardian”), which provides skilled hospice services in Grayson, Fannin, Collin, Cook, Denton, and Hunt counties in Texas, and Bryan, Choctaw, Atoka, Pushmataha, Johnston, Coal, Marshall, Murray, Pontotoc, and Love counties in Oklahoma. “We are very excited to expand the reach of our hospice operations in the states of Texas and Oklahoma,” said Brent Guerisoli, Chief Executive Officer of Pennant. Our strategy of local leaders empowered to meet the needs of local communities has resonated deeply in rural communities across our platform and we look...

Ansys Announces Financial Results With Record Q3 Cash Flow and ACV

Written by Customer Service on November 1, 2023. Posted in Earnings Releases And Operating Results.

Updates FY 2023 Outlook Details related to our financial guidance, including assumptions, are included in our prepared remarks document. / Key Highlights – Q3 2023 GAAP and non-GAAP revenue of $458.8 million GAAP diluted earnings per share of $0.64 and non-GAAP diluted earnings per share of $1.41 GAAP operating profit margin of 15.2% and non-GAAP operating profit margin of 34.1% Operating cash flows of $160.8 million and unlevered operating cash flows of $170.6 million Annual contract value (ACV) of $457.5 million Deferred revenue and backlog of $1,205.7 million on September 30, 2023 Incremental restrictions for export to China negatively impacted revenue and ACV by $20.0 million Reaffirm long-term outlook from 2022 to 2025 of 12% constant currency ACV growth, including tuck-in M&A, and $3 billion of cumulative unlevered...

Host Hotels & Resorts, Inc. Reports Third Quarter 2023 Results

Written by Customer Service on November 1, 2023. Posted in Earnings Releases And Operating Results.

Maintains Midpoint of Full Year RevPAR Growth Guidance Repurchases $100 Million of Common Shares in QuarterAnnounces Hyatt Transformational Capital Program BETHESDA, Md., Nov. 01, 2023 (GLOBE NEWSWIRE) — Host Hotels & Resorts, Inc. (NASDAQ: HST) (the “Company”), the nation’s largest lodging real estate investment trust (“REIT”), today announced results for third quarter of 2023. OPERATING RESULTS (unaudited, in millions, except per share and hotel statistics) Quarter ended September 30, Year-to-date ended September 30, 2023 2022 Percent Change 2023 2022 Percent Change Revenues $ 1,214 $ 1,189 2.1 % $ 3,988 $ 3,644 9.4 % Comparable hotel revenues⁽¹⁾ 1,181 1,188 (0.6 %) 3,909 3,522 11.0 % Comparable hotel Total RevPAR⁽¹⁾ 312.35 314.25 (0.6 %) 348.41 313.90 11.0 % Comparable...

MKS Instruments Reports Third Quarter 2023 Financial Results

Written by Customer Service on November 1, 2023. Posted in Earnings Releases And Operating Results.

Revenue of $932 million, in-line with the midpoint of guidance GAAP gross margin of 45.7% and Non-GAAP gross margin of 47.1%, above the high-end of guidance GAAP operating margin of 12.6% and Non-GAAP operating margin of 21.8%, above the high-end of guidance GAAP net income per diluted share of $0.58 and Non-GAAP net earnings per diluted share of $1.46, above the high-end of guidance Operating cash flow of $160 million and free cash flow of $142 million ANDOVER, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today reported third quarter 2023 financial results. “We executed well in delivering strong profitability in the third quarter, despite a muted demand environment across our end markets,” said John T.C. Lee, President and...

Day: November 1, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice